Concepedia

Kenneth V. Lieberman

KV

17

Publications

1.4K

Citations

16

H-Index

1985

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Hackensack University Medical Center

University of Michigan

New York University

University of Washington

Kenneth V. Lieberman is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, chronic kidney disease, and nephrology.

ORCID

Top concepts

Publications per year

1985–2023

17

Publications

17

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Larry A. Greenbaum, Marc Fila, Gianluigi Ardissino et al. · Kidney International · 2016 · 286 citations · Full text

A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.

Kenneth V. Lieberman, Amir Tejani · Journal of the American Society of Nephrology · 1996 · 190 citations

, , +13

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

Howard Trachtman, Peter J. Nelson, Sharon G. Adler et al. · Journal of the American Society of Nephrology · 2018 · 181 citations · Full text

FOLLOW-UP OF CYCLOSPORINE-TREATED PEDIATRIC RENAL ALLOGRAFT RECIPIENTS AFTER CESSATION OF PREDNISONE

Lewis Reisman, Kenneth V. Lieberman, L Burrows et al. · Transplantation · 1990 · 107 citations

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

Michelle N. Rheault, Charles E. Alpers, Jonathan Barratt et al. · New England Journal of Medicine · 2023 · 94 citations

Rows per page

1–5 of 17